Home
Medicines
Companies
COVID-19
Direct Healthcare Professional Communications
Active Ingredients
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Companies
COVID-19
More
expand_more
Login
menu
Home
Active Ingredients
Pembrolizumab
Pembrolizumab
Medicine
Status
PIL
SPC
XPIL
Legal Category
Active Ingredient(s)
Company
KEYTRUDA 25 mg/mL concentrate for solution for infusion
Updated
PIL
13/05/22
SPC
13/05/22
No
A
Pembrolizumab
MSD Ireland (Human Health) Limited
Documents associated with this medicine were updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
